May 14, 2020 / 12:38 PM / 14 days ago

BRIEF-Pluristem Provides 28-Day Follow Up For Ventilator-Dependent Covid-19 Patients Under Compassionate Use Program In Israel And U.S.

May 14 (Reuters) - Pluristem Therapeutics Inc:

* PLURISTEM PROVIDES 28-DAY FOLLOW UP FOR VENTILATOR-DEPENDENT COVID-19 PATIENTS UNDER COMPASSIONATE USE PROGRAM IN ISRAEL AND U.S.

* PLURISTEM THERAPEUTICS INC - 87.5% SURVIVAL RATE OF PATIENTS ON INVASIVE MECHANICAL VENTILATION INJECTED WITH PLX CELLS

* PLURISTEM THERAPEUTICS - 75% WERE OFF ANY MECHANICAL VENTILATION AMONG 8 PATIENTS TREATED WITH PLX CELLS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below